Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02267603
Brief Title: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

First Submitted : October 14, 2014
First Submitted that Met QC Criteria : October 14, 2014
First Posted : October 17, 2014 (Estimate)

Results First Submitted : February 5, 2019
Results First Submitted that Met QC Criteria : February 5, 2019
Results First Posted : March 1, 2019

Last Update Submitted that Met QC Criteria : March 19, 2021
Last Update Posted : March 22, 2021